In landmark analyses restricted to patients with continued treatment at 3 and 6 months, finerenone was consistently associated with lower risks of MACE, MAKE, and all-cause mortality compared with spironolactone (Supplementary Table 7)
The Best GLP-1 Tracker App for Daily Follow-Through Track shots or pills, injection sites, food, protein, fiber, water, side effects, weight, progress photos, medication context, Journey Cards, and daily GLP-1 support in one app
The case of Spain This study examines the complex challenges inherent in the public-public partnership established in 2023 between SEPESthe Public Land Entity under the Spanish Ministry of Transport, Mobility, and Urban Agenda (MITMA)and the Ministry of Defence (MoD)
Andrologia 53 (2), e13725
The concept of being genuinely hungry becomes unfamiliar to many users